Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas

Name: Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
License: Public Domain

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pancreatic-cancer

pancreatic cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174853
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.